Surgery for Breast Cancer: 974 Real Stories

974 stories match breast cancer and surgery. 653 of them mention chemotherapy.

Cancer Stories

Roxanne, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.org
OutcomeCancer-Free / NED
Vanessa, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Vanessa's Survivor Story

Patient Info: Vanessa Cuccurullo, Female | Stage I

Clear post-surgery mammogram/check-up after Stage I breast cancer treatment, healed reconstruction and reduction, and return to annual monitoring.

breastcancer.org
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Breast CancerBreast Cancer

Faith And Humility: Stage I Breast Cancer treatment and follow-up story

Patient Info: Anonymized, Female | Stage I

Completed surgery, chemotherapy, and radiotherapy for early breast cancer about 9 months before the story and was living in recovery; no explicit NED/cancer-free status is stated.

breastcancer.org
OutcomeSurvivorship / Surveillance
Michele, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Michele's Survivor Story

Patient Info: Michele Adams, Female

Breast cancer survivor after bilateral mastectomy and reconstruction; the source focuses on recovery, reconstruction, and a career change rather than formal disease status.

breastcancer.org
OutcomeSurvivorship / Surveillance
Karen, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Karen's Survivor Story

Patient Info: Karen Powell, Female, Under 40 | Stage I

Breast cancer survivor after diagnosis with Stage I invasive ductal carcinoma and bilateral mastectomy/reconstruction planning; source emphasizes early detection, advocacy, and survivorship rather than formal NED wording.

breastcancer.org
OutcomeSurvivorship / Surveillance
Cher, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.org
OutcomeCancer-Free / NED
Amy, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Amy's Survivor Story

Patient Info: Amy Mannarino, Female, 50s | Stage IV

Metastatic Site: Brain

After brain metastasis surgery and 3 radiation sessions, Amy was doing well with no evidence of disease; the source specifically distinguishes NED from being cured or cancer-free in the setting of metastatic disease.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Nicole, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Jim, who was diagnosed with Breast CancerBreast Cancer

HER2-Positive Breast Cancer: Jim's Patient Story

Patient Info: Jim Keegan, Male, 70+

Biomarkers: HER2-positive; BRCA1/BRCA2 negative

Jim completed surgery, chemotherapy and 1 year of Herceptin for early-stage HER2-positive male breast cancer, then continued tamoxifen and yearly MSK surveillance while advocating for male breast cancer awareness.

Memorial Sloan Kettering
OutcomeCare Ongoing
Michelle, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Michelle's Survivor Story

Patient Info: Michelle Kang, Female, Under 40 | Stage I

Biomarkers: Hormone-positive breast cancer; no suspicious inherited genetic mutation reported

Michelle was 6 years cancer-free after Stage 1B hormone-positive breast cancer while continuing hormone therapy, Zometa, Signatera blood testing, reconstruction follow-up, and survivorship monitoring.

City of Hope
OutcomeCancer-Free / NED
Dwan, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Dwan's Survivor Story

Patient Info: Dwan Thomas, Female | Stage II

Biomarkers: HER2-negative; estrogen-positive

Dwan completed treatment for Stage II HER2-negative, estrogen-positive invasive ductal carcinoma in 2017 and later became active in MD Anderson advocacy and fundraising efforts.

MD Anderson
OutcomeSurvivorship / Completed Treatment
Valerie, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Valerie's Survivor Story

Patient Info: Valerie Hamilton, Female, 50s | Stage Metastatic/Advanced

Biomarkers: Triple-negative breast cancer; ER-negative; PR-negative; HER2-negative

Valerie completed chemotherapy, lumpectomy and radiation for locally advanced triple-negative breast cancer and preserved her breast/body image; no explicit NED or cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Rachel, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II BRCA2 Breast Cancer: Rachel's Patient Story

Patient Info: Rachel Zitofsky, Female, Under 40 | Stage II

Biomarkers: BRCA2 mutation

Rachel was doing well 4.5 years after Stage II breast cancer diagnosis and continued tamoxifen; her BRCA2 result also led her sister to expanded testing and preventive care.

Memorial Sloan Kettering
OutcomeCare Ongoing
Jill, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Jill's Survivor Story

Patient Info: Jill, Female | Stage I

Biomarkers: Gene profile used to help avoid chemotherapy; specific biomarkers not reported

Jill completed lumpectomy, sentinel node biopsy and 4 weeks of hypofractionated radiation for Stage I invasive ductal carcinoma, avoided chemotherapy, and moved into recovery; no explicit NED/cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Eutha, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan Kettering
OutcomeSurvivorship / Surveillance
Rosanna, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Rosanna's Survivor Story

Patient Info: Rosanna Silber, Female, Under 40 | Stage I

Rosanna had no evidence of cancer after treatment for Stage I breast cancer and later cervical cancer, with ongoing checkups every 6 months for cervical cancer and annually for breast cancer.

Memorial Sloan Kettering
OutcomeCancer-Free / NED
Cookie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Triple-Negative Breast Cancer: Cookie's Survivor Story

Patient Info: Cookie Joe, female | Stage III

Biomarkers: triple-negative

More than 5 years after her April 2021 diagnosis, she remains cancer-free (since December 2022) and continues breast-cancer advocacy, fundraising, and blood-donation efforts.

MD Anderson
OutcomeCancer-Free / NED
Jennifer, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Jennifer's Patient Story

Patient Info: Jennifer Feinberg, Female, 40s | Stage IV

Biomarkers: HER2-positive

Metastatic Site: brain

8+ years after her initial breast cancer diagnosis, she was living with metastatic HER2-positive breast cancer with brain metastases and receiving trastuzumab as her tenth line of treatment.

Dana-Farber
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

HER2-positive breast cancer complicated by severe anemia during chemotherapy

Patient Info: Anonymized, female, 40s | Stage III

Biomarkers: ER-negative; PR-negative; HER2-positive; germline BRCA1 likely pathogenic mutation

At 4.5-year follow-up, she remained free of breast-cancer recurrence and had no recurrence of the severe treatment-related anemia.

PubMed Central
OutcomeCancer-Free / NED
Jane, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Jane's Patient Story

Patient Info: Jane, Female, 50s | Stage II

Nearly 3 years into her breast-cancer journey, she was continuing long-term hormone therapy and active patient advocacy.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
A patient, who was diagnosed with Breast Squamous Cell CarcinomaBreast Cancer

Complete response after chemotherapy for metaplastic breast cancer

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-negative; weak PR-positive; HER2-negative

Surgery found no residual invasive or in situ breast cancer, and all 3 sentinel lymph nodes were negative, confirming a pathologic complete response.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Radiation-related morphea years after breast cancer treatment

Patient Info: Anonymized, Female, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative

At follow-up in March 2026, more than 10 years after her breast cancer diagnosis, she remained free of oncologic recurrence and had completed 10 years of tamoxifen.

PubMed Central
OutcomeCancer-Free / NED